1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Monkey |
Cat.No | ABC-H0015Y |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Epithelial |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Intestine |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Monkey Primary Cells |
Cynomolgus Monkey Small Intestinal Epithelial Cells are primary epithelial cells isolated from the small intestine of healthy Cynomolgus monkeys (Macaca fascicularis), a non-human primate species used in preclinical studies. These cells originate from the mucosal lining and are terminally differentiated, including mucus-secreting goblet cells and absorptive enterocytes. They exhibit classic epithelial morphology, form tight junctions, and grow as a monolayer under standard conditions (37°C, 5% CO₂). The cells are typically at early passage (P1–P3) to ensure functional integrity. They form a selectively permeable barrier regulating nutrient absorption and protecting against pathogens, and are involved in immunomodulation and secretion of antimicrobial peptides.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
The application of cynomolgus monkey small intestinal epithelial cells offers significant potential across fields related to intestinal health and regenerative medicine. By utilizing in vitro models of these cells, researchers can investigate the regenerative potential of intestinal stem/progenitor cells and their potential in addressing degenerative conditions such as colitis, inflammatory bowel disease, intestinal infections, and radiation injury. Understanding the factors and pathways involved in the controlled differentiation of stem/progenitor cells into tissue-specific lineages may significantly aid the development of effective clinical protocols. Moreover, studying the shedding of senescent enterocytes and the disturbance of intestinal homeostasis in inflammatory conditions can provide valuable insights into the underlying mechanisms and potential therapeutic interventions.